Merck opens €300 M Asia-Pacific bioprocessing centre in Daejeon, South Korea

Merck, a leading science and technology company, has opened its new Asia-Pacific Bioprocessing Production Centre in Daej...

November 2, 2026 | Monday | News
BioMarin signs deal worth $475 M with Korea's GC Biopharma and Hanmi Pharm for potential treatment of Fabry Disease

US-based BioMarin Pharmaceutical Inc. has entered into an exclusive worldwide license agreement with South Korea-based G...

October 30, 2026 | Friday | News
BIX 2026 Closes: From Brain Signals to Business Signals, Korea's Biotech Agenda Comes Into Focus

BIOPLUS-INTERPHEX KOREA 2026 closed at COEX on Friday with its shortest conference day and, in some ways, its most forwa...

October 30, 2026 | Friday | Analysis
Stem-Cell Therapies Are No Longer a Distant Promise — The Real Challenge Is Delivering Lasting Results

Regenerative medicine is entering a defining phase as stem-cell research moves beyond laboratory discoveries towards cli...

October 29, 2026 | Thursday | Analysis
BIX 2026 Day 2: When Big Pharma Comes Knocking, Is Korea Ready to Answer?

If Day 1 of BIX 2026 asked what makes a Korean asset partnerable, Day 2 asked what happens once someone wants it. Thursd...

October 29, 2026 | Thursday | Analysis
The Early-Mover Window: Why Biohealth Companies Should Look at Chuncheon Now

Ask most investors to name South Korea's bio clusters and the list starts with Songdo, moves on to Pangyo and Osong, and...

October 29, 2026 | Thursday | Analysis
“The Future of Brain–Computer Interfaces Will Be Measured by Independence, Not Laboratory Performance”

Brain–computer interfaces (BCIs) are entering a new phase of technological development, moving beyond experimental...

October 29, 2026 | Thursday | News
BIX 2026 Day 1: Seoul Moves From the Lab Bench to the Deal Table

BIOPLUS-INTERPHEX KOREA 2026 opened at COEX in Seoul on Wednesday with a first day that made its priorities plain. Hoste...

October 28, 2026 | Wednesday | Analysis
CELSET launches Korean Botulinum Toxin Type A brand for International Markets

CELSET INC., a Korean biotechnology company specialising in medical aesthetics, has launched SOLTOX, its botulinum toxin...

October 28, 2026 | Wednesday | News
Korea's Ardens Lifescience wins MedTech Innovator Asia Pacific 2026 Grand Prize

MedTech Innovator (MTI), the world’s largest accelerator of medical device, digital health, and diagnostic compani...

October 27, 2026 | Tuesday | News
Kaigene signs agreement worth $580 M with Korea's Celltrion for next-gen Anti-APRIL Antibody KG013

Kaigene, Inc., a US-based biotechnology company developing antibody medicines for autoimmune diseases, has announced an ...

October 26, 2026 | Monday | News
Taiwan's HanchorBio joins forces with Korea's Aston Sci to unlock potential of next-gen immunotherapy through cancer vaccine combinations

Taiwan-based HanchorBio, Inc., a global clinical-stage biotechnology company, and Aston Sci, Inc., a South Korea-based c...

October 22, 2026 | Thursday | News
Korea's Samsung Bioepis enters into landmark 10-Year agreement to supply Eculizumab to Brazil

South Korea-based Samsung Bioepis has announced a landmark 10-year agreement with its local partners in Brazil—sta...

October 22, 2026 | Thursday | News
Korea's NeuroXT receives US FDA 510(k) clearance for AI software supporting prognostic assessment in Mild Cognitive Impairment

South Korea-based startup NeuroXT Inc., a medical device manufacturer, has announced that NEXT-Cue, its AI-based Softwar...

October 21, 2026 | Wednesday | News
Researchers in Korea explore use of smartphones to help detect lung problems in children

Respiratory disease in children is a major global concern. Although stethoscopes help clinicians detect abnormal lung so...

October 19, 2026 | Monday | News
Swiss firm Alentis Therapeutics partners with Korea's PinotBio to develop next-gen ADCs targeting claudin-1

Swiss firm Alentis Therapeutics and South Korea based PinotBio have entered into a research collaboration and licensing ...

October 15, 2026 | Thursday | News
Korea's GCCL signs MoU with LabConnect to expand global clinical trial collaboration

GCCL, a South Korea-based leading global clinical trial central laboratory, has signed a Memorandum of Understanding (Mo...

October 13, 2026 | Tuesday | News
Korea's NTL HEALTHCARE announces global launch of On-Premises AI Solution 'CerviCARE® AI AT'

South Korea-based NTL HEALTHCARE, a women's health AI company, has announced the global launch of CerviCARE® AI AT, ...

October 16, 2026 | Friday | News
Korea's Lunit collaborates with US-based Discovery Life Sciences to expand AI-powered tissue analysis for biopharma research

South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a strateg...

October 12, 2026 | Monday | News
Korea's LOTTE Biologics inks US-based manufacturing agreement with Alvotech to increase global supply

South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global ...

October 9, 2026 | Friday | News
Korea's GC Cell and Israel-based QuantHealth collaborate to optimise clinical cevelopment of cell therapy product

South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and...

October 8, 2026 | Thursday | News
Taiwan's Energenesis Biomedical joins hands with Korea-based Yoo Young Pharm to develop treatment for diabetic foot ulcers

Taiwan-based Energenesis Biomedical has signed a Memorandum of Understanding (MoU) with Yoo Young Pharm (YYO), a South K...

October 6, 2026 | Tuesday | News
Korea's SK pharmteco invests more than $200 M to expand small molecule and peptide capacity in US

SK pharmteco, a subsidiary of SK Inc., the strategic investment company for SK Group, South Korea’s second-la...

October 6, 2026 | Tuesday | News
Korean govt expands market entry support for dermatology companies in Europe

The Ministry of Health and Welfare, South Korea government, has announced that it will open K-Beauty experience and reta...

September 30, 2026 | Wednesday | News
Korea's Lunit expands AI-powered breast cancer screening across Stockholm Region

South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced that its ...

September 29, 2026 | Tuesday | News